NEW YORK (GenomeWeb News) – The US Food and Drug Administration has approved Roche's HIV viral load test, the Swiss drug and diagnostics firm announced today.

The test, called Cobas TaqMan HIV-1 Test, v2.0, will be available later this year and targets two highly conserved regions of the HIV-1 genome, avoiding any regions that are targeted by current drugs. As a result, the test provides increased reliability "even with rare mismatches in primer/probe binding sites and when mutations are present," Roche said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: new gene linked to ocular coloboma, new statistical model for interrogating gene expression networks, and more.

With a new collection, PLOS highlights negative results it has published.

A pair of researchers examines political leanings and views on genomics, finding more of a role for optimism and pessimism in people's views.

The genome of the carnivorous bladderwort is smaller than many other plant genomes, but it still holds on to important genes.